Last reviewed · How we verify
Placebo normal saline PENG block — Competitive Intelligence Brief
marketed
Anesthesia/Pain Management
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo normal saline PENG block (Placebo normal saline PENG block) — University of California, San Diego. Normal saline placebo serves as an inert control in the PENG (Pectoral Nerves) block study, providing no active pharmacological effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo normal saline PENG block TARGET | Placebo normal saline PENG block | University of California, San Diego | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo normal saline PENG block CI watch — RSS
- Placebo normal saline PENG block CI watch — Atom
- Placebo normal saline PENG block CI watch — JSON
- Placebo normal saline PENG block alone — RSS
Cite this brief
Drug Landscape (2026). Placebo normal saline PENG block — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-normal-saline-peng-block. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab